ASML outlook bullish through 2030 due to AI boom -CEO says
By Toby Sterling and Nathan Vifflin AMSTERDAM (Reuters) -Computer chip equipment maker ASML (AS:ASML), facing the threat of more U.S.-led curbs on trade with China, is upbeat on...
By Toby Sterling and Nathan Vifflin AMSTERDAM (Reuters) -Computer chip equipment maker ASML (AS:ASML), facing the threat of more U.S.-led curbs on trade with China, is upbeat on...
Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB), Gilead...
As Nvidia (NASDAQ:NVDA) approaches another earnings report, analysts at Wedbush and Raymond (NS:RYMD) James are reiterating their bullish stance on the stock,...
BARCELONA (Reuters) - Chinese carmaker Chery will delay the start of vehicle production in Spain to the fourth quarter of 2025, an executive at its Spanish partner Ebro said on...
Shares of Merck KGaA (ETR:MRCG) fell over 4% on Thursday following a mixed reception to its third-quarter earnings report and revised full-year guidance. While...
By Leroy Leo (Reuters) -Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit...
AMSTERDAM (Reuters) - ASML (AS:ASML) CEO Christophe Fouquet said on Thursday the ongoing boom in AI computer chips would help ASML by increasing the relative share of advanced...
This article summarizes the most significant insider buys and sells for US stocks from Wednesday, November 13, 2024. Top Insider Buys: • Oscar Health Inc. (NYSE:OSCR) saw...
The S&P 500 is hovering near what strategists at Sevens Report suggest could be its "fundamental fair value," the daily financial newsletter said in its Thursday...
By Kirstin Ridley LONDON (Reuters) - Britain's Financial Conduct Authority (FCA) on Wednesday softened proposals to publicly name some companies under investigation after a...